查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712546

全球數位全像顯微鏡市場 - 2025-2033

Global Digital Holographic Microscopy Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球數位全像顯微鏡市場規模達到 4.766 億美元，預計到 2033 年將達到 30.5689 億美元，在 2025-2033 年預測期內的複合年成長率為 20.4%。

數位全像顯微鏡 (DHM) 是一種使用乾涉結構進行定量相位成像 (QPI) 的流行技術。單元件乾涉儀由於其簡單、穩定和低成本而特別有用。一種稱為單元件反射式數位全像顯微鏡（SER-DHM）的簡單共路干涉佈局使用單一一維衍射光柵來照明和產生數位全像圖。本技術採用單次操作原理實現反射/不透明物體的 QPI 和形貌分析，並已通過實驗驗證。

市場動態：

駕駛員和約束裝置

成像和顯示技術的進步

由於成像和顯示技術的進步，全球數位全像顯微鏡市場正在成長。相機解析度、光源、感光元件和即時影像處理的改進提高了DHM系統的性能、準確性和可用性。高速攝影機和高靈敏度探測器使研究人員能夠以出色的清晰度和時間解析度捕捉動態生物過程。

3D顯示技術和軟體驅動的視覺化工具使得即時重建和解釋複雜的全像資料成為可能，從而促進對標本進行更直覺和互動的分析。這些進步擴展了 DHM 在細胞生物學、奈米技術和材料科學中的應用，在這些領域中，精確、無標記和定量成像至關重要。隨著成像和顯示技術的發展，有望降低技術複雜性和操作限制，使 DHM 在學術、臨床和工業領域更易於存取和更具吸引力。

實施成本高

全球數位全像顯微鏡市場因實施成本高而面臨挑戰。先進的系統需要複雜的光學元件、高解析度攝影機和強大的資料處理軟體，這會增加初始投資。整合到現有實驗室可能需要基礎設施改造和專門培訓，進一步增加營運費用。這些成本可能會對預算有限的中小型研究機構或實驗室造成障礙，減緩其廣泛採用，尤其是在發展中地區或財政資源有限的組織中。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 顯微鏡類型的片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 成像和顯示技術的進步
      • 對 3D 視覺化和分析的需求日益成長
    • 限制
      • 實施成本高
      • 技術挑戰與局限性
    • 機會
      • 與擴增實境 (AR) 和虛擬實境 (VR) 的整合
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大、最暢銷品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：按顯微鏡類型

  • 傳輸DHM
  • 反射DHM
  • 離軸DHM
  • 內聯 DHM

第6章：按應用

  • 生命科學
  • 材料科學
  • 半導體
  • 微電子
  • 其他

第 7 章：按最終用戶

  • 學術及研究機構
  • 製藥和生物技術公司
  • 醫院和診所
  • 製造業

第8章：區域市場分析與成長機會

  • 北美洲
    • 關鍵區域特定動態
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 關鍵區域特定動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 南美洲
    • 關鍵區域特定動態
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 關鍵區域特定動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域特定動態

第9章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第10章：公司簡介

  • Lyncee Tec
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Holoxica Limited
  • Phase Holographic Imaging AB
  • Ovizio Imaging Systems
  • Nanolive SA
  • Holmarc Opto-Mechatronics Ltd
  • DAEIL SYSTEMS CO., LTD

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: HCIT9511

The global digital holographic microscopy market reached US$ 476.60 million in 2024 and is expected to reach US$ 3056.89 million by 2033, growing at a CAGR of 20.4% during the forecast period 2025-2033.

Digital holographic microscopy (DHM) is a popular technique for quantitative phase imaging (QPI) using interferometric architectures. Single-element interferometers are particularly useful due to their simplicity, stability, and low cost. A simple common-path interferometric layout called single-element reflective digital holographic microscopy (SER-DHM) uses a single one-dimensional diffraction grating for illuminating and generating digital holograms. This technique enables QPI and topography analysis of reflective/opaque objects using a single-shot operation principle, which has been experimentally validated.

Market Dynamics: Drivers & Restraints

Advancements in Imaging and Display Technologies

The global digital holographic microscopy market is growing due to advancements in imaging and display technologies. Improvements in camera resolution, light sources, sensors, and real-time image processing have improved the performance, accuracy, and usability of DHM systems. High-speed cameras and high-sensitivity detectors enable researchers to capture dynamic biological processes with exceptional clarity and temporal resolution.

3D display technologies and software-driven visualization tools have made it possible to reconstruct and interpret complex holographic data in real-time, facilitating more intuitive and interactive analysis of specimens. These advancements have expanded DHM applications in cell biology, nanotechnology, and material science, where precise, label-free, and quantitative imaging is critical. As imaging and display technologies evolve, they are expected to reduce technical complexity and operational limitations, making DHM more accessible and appealing across academic, clinical, and industrial domains.

High Cost of Implementation

The global digital holographic microscopy market faces challenges due to high implementation costs. Advanced systems require sophisticated optical components, high-resolution cameras, and powerful data processing software, increasing initial investment. Integration into existing labs may require infrastructure modifications and specialized training, further increasing operational expenses. These costs can be a barrier for small- and medium-sized research institutions or labs with limited budgets, slowing widespread adoption, especially in developing regions or organizations with limited financial resources.

Segment Analysis

The global digital holographic microscopy market is segmented based on microscope type, application, end-user, and region.

Microscope Type:

The transmission DHM from the microscope type segment is expected to dominate the digital holographic microscopy market with the highest market share.

Transmission Digital Holographic Microscopy (DHM) is a sophisticated imaging technique that uses light transmission to capture holograms of microscopic structures. It records the phase shift of light waves, allowing for quantitative phase imaging and three-dimensional visualization without the need for dyes or labels.

The increasing demand for non-invasive imaging methods is driving the adoption of transmission digital holographic microscopy (DHM). This technique offers high-resolution, quantitative phase imaging of live cells, making it ideal for biomedical research, pharmaceutical development, pathology, cell biology, virology, and cancer diagnostics. It also supports long-term live-cell imaging without phototoxic effects, making it suitable for regenerative medicine and stem cell research. As academic institutions invest in high-end imaging systems, DHM adoption is expected to rise.

Geographical Analysis

North America is expected to hold a significant position in the digital holographic microscopy market, with the highest market share

North America is expected to dominate the global digital holographic microscopy market due to its advanced research facilities and healthcare infrastructure. The demand for non-invasive imaging techniques in biomedical research and clinical diagnostics has accelerated their adoption. Investments in nanotechnology, life sciences, and material science research, particularly in the US, are driving market growth. The presence of leading microscopy and imaging technology companies and government funding for R&D initiatives further enhances the market's expansion. The focus on precision medicine and real-time cellular imaging is expected to drive demand for digital holographic microscopy solutions.

For instance, in September 2024, Researchers have created a smartphone-based digital holographic microscope that offers precise 3D measurements, potentially expanding its applications to educational settings and point-of-care diagnostics in resource-limited settings.

Competitive Landscape

The major global players in the digital holographic microscopy market include Lyncee Tec, Holoxica Limited, Phase Holographic Imaging AB, Ovizio Imaging Systems, Nanolive SA, Holmarc Opto-Mechatronics Ltd, and DAEIL SYSTEMS CO., LTD, among others.

Key Developments

  • In March 2025, Honeywell introduced Digital Holographic Microscopy (DHM), a technology that uses artificial intelligence to efficiently count and classify microscopic particles or cells, offering significant potential in industries requiring rapid analysis and streamlined operations.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global digital holographic microscopy market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Microscope Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Advancements in Imaging and Display Technologies
      • 3.1.1.2. Increasing Need for 3D Visualization and Analysis
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Implementation
      • 3.1.2.2. Technical Challenges and Limitations
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Augmented Reality (AR) and Virtual Reality (VR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Microscope Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 5.1.2. Market Attractiveness Index, By Microscope Type
  • 5.2. Transmission DHM*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Reflection DHM
  • 5.4. Off-axis DHM
  • 5.5. Inline DHM

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Life Sciences*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Material Sciences
  • 6.4. Semiconductors
  • 6.5. Microelectronics
  • 6.6. Others

7. By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 7.1.2. Market Attractiveness Index, By End User
  • 7.2. Academic & Research Institutes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pharmaceutical & Biotechnology Companies
  • 7.4. Hospitals & Clinics
  • 7.5. Manufacturing Industries

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Lyncee Tec*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Holoxica Limited
  • 10.3. Phase Holographic Imaging AB
  • 10.4. Ovizio Imaging Systems
  • 10.5. Nanolive SA
  • 10.6. Holmarc Opto-Mechatronics Ltd
  • 10.7. DAEIL SYSTEMS CO., LTD

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us